tiprankstipranks
Provexis PLC (GB:PXS)
LSE:PXS

Provexis (PXS) Share Price & Analysis

2 Followers

PXS Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range0.41p - 0.90p
Previous Close0.6p
Volume1.18M
Average Volume (3M)806.40K
Market Cap
£13.52M
Enterprise Value12.61M
Total Cash (Recent Filing)£379.12K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)
Beta0.25
Sep 26, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,217,821,523
10 Day Avg. Volume2,898,729
30 Day Avg. Volume806,396
Standard Deviation0.25
R-Squared0.03
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)8979.91
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.05%0.00%0.00%97.95%
2.05%
Insiders
0.00% Other Institutional Investors
97.95% Public Companies and
Individual Investors

PXS FAQ

What was Provexis PLC’s price range in the past 12 months?
Provexis PLC lowest share price was 0.41p and its highest was 0.90p in the past 12 months.
    What is Provexis PLC’s market cap?
    Currently, no data Available
    When is Provexis PLC’s upcoming earnings report date?
    Provexis PLC’s upcoming earnings report date is Sep 26, 2024 which is in 119 days.
      How were Provexis PLC’s earnings last quarter?
      Provexis PLC released its earnings results on Dec 29, 2023. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
        Is Provexis PLC overvalued?
        According to Wall Street analysts Provexis PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Provexis PLC pay dividends?
          Provexis PLC pays a Notavailable dividend of 0.5p which represents an annual dividend yield of N/A. See more information on Provexis PLC dividends here
            What is Provexis PLC’s EPS estimate?
            Provexis PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Provexis PLC have?
            Provexis PLC has 2,262,945,300 shares outstanding.
              What happened to Provexis PLC’s price movement after its last earnings report?
              Provexis PLC reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Provexis PLC?
                Currently, no hedge funds are holding shares in GB:PXS
                ---

                Provexis Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -17.65%
                12-Months-Change

                Fundamentals

                Return on Equity
                -41.86%
                Trailing 12-Months
                Asset Growth
                -23.80%
                Trailing 12-Months

                Company Description

                Provexis PLC

                Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is a heart health functional food ingredient for the functional food sector. Fruitflow is a patented natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease. It generates revenue from DSM Alliance Agreement; Fruitflow+ Omega 3 and Other income.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Tristel
                OptiBiotix Health
                HUTCHMED (China) Limited
                Synairgen
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis